BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 22922303)

  • 1. Angiopoietins in angiogenesis.
    Fagiani E; Christofori G
    Cancer Lett; 2013 Jan; 328(1):18-26. PubMed ID: 22922303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiopoietin: a TIE(d) balance in tumor angiogenesis.
    Shim WS; Ho IA; Wong PE
    Mol Cancer Res; 2007 Jul; 5(7):655-65. PubMed ID: 17634421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Ang/Tie signaling in lymphangiogenesis.
    Wu X; Liu N
    Lymphology; 2010 Jun; 43(2):59-72. PubMed ID: 20848993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tie-1: A potential target for anti-angiogenesis therapy.
    Yang P; Chen N; Jia JH; Gao XJ; Li SH; Cai J; Wang Z
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):615-622. PubMed ID: 26489611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dynamic roles of angiopoietins in tumor angiogenesis.
    Yu Q
    Future Oncol; 2005 Aug; 1(4):475-84. PubMed ID: 16556024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the Angiopoietins in vascular morphogenesis.
    Thomas M; Augustin HG
    Angiogenesis; 2009; 12(2):125-37. PubMed ID: 19449109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma.
    Mitsuhashi N; Shimizu H; Ohtsuka M; Wakabayashi Y; Ito H; Kimura F; Yoshidome H; Kato A; Nukui Y; Miyazaki M
    Hepatology; 2003 May; 37(5):1105-13. PubMed ID: 12717391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.
    Currie MJ; Gunningham SP; Han C; Scott PA; Robinson BA; Harris AL; Fox SB
    Clin Cancer Res; 2001 Apr; 7(4):918-27. PubMed ID: 11309342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of angiopoietin-1, angiopoietin-2 and their receptors tie-1 and tie-2 in the very early human placenta.
    Seval Y; Sati L; Celik-Ozenci C; Taskin O; Demir R
    Placenta; 2008 Sep; 29(9):809-15. PubMed ID: 18675456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do angiopoietins Tie in with vascular endothelial growth factors?
    Saharinen P; Bry M; Alitalo K
    Curr Opin Hematol; 2010 May; 17(3):198-205. PubMed ID: 20375888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
    Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases.
    Etoh T; Inoue H; Tanaka S; Barnard GF; Kitano S; Mori M
    Cancer Res; 2001 Mar; 61(5):2145-53. PubMed ID: 11280779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK; Blann A; Beevers DG; Lip GY
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems.
    Eklund L; Kangas J; Saharinen P
    Clin Sci (Lond); 2017 Jan; 131(1):87-103. PubMed ID: 27941161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling.
    Eklund L; Olsen BR
    Exp Cell Res; 2006 Mar; 312(5):630-41. PubMed ID: 16225862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling.
    Harfouche R; Malak NA; Brandes RP; Karsan A; Irani K; Hussain SN
    FASEB J; 2005 Oct; 19(12):1728-30. PubMed ID: 16049136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of angiopoietins in tumor angiogenesis and cancer development.
    Thapa K; Khan H; Kaur G; Kumar P; Singh TG
    Biochem Biophys Res Commun; 2023 Dec; 687():149130. PubMed ID: 37944468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders.
    Akwii RG; Mikelis CM
    Drugs; 2021 Oct; 81(15):1731-1749. PubMed ID: 34586603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Roles of angiopoietins family and its receptor in the pathogenesis and regulation of corneal neovascularization].
    Wang X; Wang WT; Xu JJ; Hong JX
    Zhonghua Yan Ke Za Zhi; 2008 Jul; 44(7):656-9. PubMed ID: 19040083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.